CD22
医学
淋巴细胞白血病
化疗
单克隆抗体
肿瘤科
内科学
抗体
白血病
免疫学
作者
Patrice Chevallier,Thibaut Leguay,Marc Delord,Cyril Šálek,Rathana Kim,Françoise Huguet,Yosr Hicheri,Ulla Wartiovaara‐Kautto,Emmanuel Raffoux,Thomas Cluzeau,Marie Balsat,Gabrielle Roth-Guépin,Emmanuelle Tavernier,Stéphane Leprêtre,Karin Bilger,Hugo Bergugnat,Ana Berceanu,Magda Alexis,Michael Doubek,Éolia Brissot
摘要
The use of inotuzumab ozogamicin (InO), a conjugated anti-CD22 monoclonal antibody, is becoming a promising frontline treatment for older patients with ALL.
科研通智能强力驱动
Strongly Powered by AbleSci AI